Literature DB >> 18196742

Neurologic dysfunction in hypothyroid, hyperlipidemic Labrador Retrievers.

Christina L Vitale1, Natasha J Olby.   

Abstract

BACKGROUND: Hypothyroidism has been associated with a variety of neurologic signs, but the mechanism for this association is not completely understood. Hypothyroidism also is associated with hyperlipidemia that predisposes to atherosclerosis, increased blood viscosity, and thromboembolic events.
OBJECTIVE: The objective is to characterize neurologic signs potentially associated with hyperlipidemia and atherosclerosis in canine hypothyroidism. ANIMALS: This study used dogs referred to North Carolina State University Veterinary Teaching Hospital for evaluation of neurologic signs.
MATERIALS AND METHODS: A retrospective study was conducted in which medical records of dogs with neurologic signs and a diagnosis of hypothyroidism and hyperlipidemia were reviewed. Details of the history, presenting signs, results of routine blood tests, thyroid tests, cerebrospinal fluid (CSF) analysis and diagnostic imaging, and response to therapy were compiled.
RESULTS: Three Labrador Retrievers and one Labrador Retriever cross fit the inclusion criteria. All dogs were hypothyroid and severely hyperlipidemic. Neurologic signs included tetraparesis, central and peripheral vestibular signs, facial paralysis, and paraparesis. Two dogs had an acute history and rapid resolution of signs consistent with an infarct, the presence of which was confirmed in 1 of the dogs by magnetic resonance imaging. Two dogs had chronic histories of cranial neuropathies and paraparesis. One of these dogs had evidence of iliac thrombosis and atherosclerosis on ultrasound examination. All dogs improved with thyroid hormone supplementation. CLINICAL RELEVANCE: Labrador Retrievers may be predisposed to the development of severe hyperlipidemia in association with hypothyroidism. One possible consequence of severe hyperlipidemia is the development of neurologic signs due to atherosclerosis and thromboembolic events.

Entities:  

Mesh:

Year:  2007        PMID: 18196742     DOI: 10.1892/07-013.1

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

1.  A case of primary hypothyroidism causing central nervous system atherosclerosis in a dog.

Authors:  Shauna L Blois; Roberto Poma; Margaret J Stalker; Dana G Allen
Journal:  Can Vet J       Date:  2008-08       Impact factor: 1.008

2.  Atherosclerosis associated with vasculopathic lesions in a golden retriever with hypercholesterolemia.

Authors:  Nicole A Boynosky; Laura Stokking
Journal:  Can Vet J       Date:  2014-05       Impact factor: 1.008

3.  Primary hyperlipidemia with associated ischemic strokes in a West Highland white terrier dog.

Authors:  Stephen Everest; Gibrann Castillo; Luis Gaitero
Journal:  Can Vet J       Date:  2020-10       Impact factor: 1.008

4.  Therapy of Canine Hyperlipidemia with Bezafibrate.

Authors:  V De Marco; K S M Noronha; T C Casado; E R Nakandakare; J C Florio; E Z Santos; C Gilor
Journal:  J Vet Intern Med       Date:  2017-04-06       Impact factor: 3.333

5.  Clinical signs, MRI findings and outcome in dogs with peripheral vestibular disease: a retrospective study.

Authors:  Rocio Orlandi; Rodrigo Gutierrez-Quintana; Beatrice Carletti; Camilla Cooper; Josep Brocal; Sara Silva; Rita Gonçalves
Journal:  BMC Vet Res       Date:  2020-05-25       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.